Xiaohong Zhang

Mrs. Xiaohong Zhang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
JWJiayi Wang
Jiayi Wang
DLDeming Li
Deming Li
FYFangzhou Ye
Fangzhou Ye
JLJian Li
Jian Li
ZQZhe Qing
Zhe Qing
LFLi Feng
Li Feng
Background and Aim: The researches on the global burden of digestive system malignancy in young populations were limited. This study aimed to comprehensively investigate the burden of early‐onset digestive system malignancy (often defined as cancers diagnosed below the age of 50) based on the Global Burden of Disease 2021.Methods: Data of incidence, prevalence, deaths, disability‐adjusted life years (DALYs), and risk factors for the five major early‐onset digestive system malignancies, including early‐onset esophageal cancer (EOEC), early‐onset gastric cancer (EOGC), early‐onset liver cancer (EOLC), early‐onset pancreatic cancer (EOPC), and early‐onset colorectal cancer (EOCRC), were extracted from GBD 2021. The average annual percent change (AAPC) was calculated using joinpoint regression analysis. The Bayesian age–period–cohort (BAPC) model was utilized to predict the burden up to 2030.Results: From 1990 to 2021, the age‐standardized incidence rate (ASIR) of early‐onset digestive system malignancies, except for EOCRC (AAPC, 0.37), showed a decreasing pattern. Meanwhile, the age‐standardized mortality rate (ASMR) and age‐standardized DALYs rate (ASDR) of early‐onset digestive system malignancy presented a downward trend. Notably, high‐middle sociodemographic index (SDI) countries experienced higher disease burdens. Dietary risk factors, tobacco, alcohol consumption, and metabolic factors were the main risk factors. The ASIR of EOEC and EOCRC was projected to increase in 2030, whereas the trend for EOGC, EOLC, and EOPC was projected to decrease.Conclusions: Early‐onset digestive system malignancy presented notable heterogeneity across gender, geography, and cancer types. This emphasizes the urgency of addressing the public health challenge of early‐onset digestive system malignancy.

20 November 2024 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
JJJun Jiang
Jun Jiang
DLDeming Li
Deming Li
FLFan Li
Fan Li
HLHuanqing Li
Huanqing Li
XZXiaohong Zhang
Xiaohong Zhang
LFLi Feng
Li Feng

1 January 2025 in Oncology Research
Verified
Journal Article
Open access
PDF file
SBSonghua Bei
Songhua Bei
QGQianqian Guo
Qianqian Guo
XWXinglei Wu
Xinglei Wu
FLFan Li
Fan Li
YXYaya Xie
Yaya Xie
XZXingxing Zhang
Xingxing Zhang
Background: Ferroptosis is a type of regulated cell death characterized by iron-dependent lipid peroxidation, which has been linked to tumor progression and therapeutic resistance. However, the contribution of lactate metabolism and its receptor, hydroxycarboxylic acid receptor 1 (HCAR1), in ferroptosis regulation in gastric cancer (GC) remains poorly understood. Focusing specifically on its effects on cell proliferation, ferroptosis regulation, and the disruption of lactate-mediated metabolic pathways, the study aimed to clarify the role of HCAR1 in GC progression. Methods: Bioinformatics analysis identified prognostic genes associated with ferroptosis in GC. Receiver operating characteristic (ROC) curves were generated to assess the diagnostic potential of the predictive genes. The biological role of HCAR1 was investigated through gain and loss-of-function experiments in GC cell lines, followed by assessments of cell viability, oxidative stress indicators, gene/protein expression, and ferroptosis sensitivity under lactate stimulation or HCAR1 modulation. Results: HCAR1 was significantly upregulated in GC tissues and linked to poor patient outcomes. Silencing HCAR1 inhibited GC cell growth and induced ferroptosis, as shown by increased levels of reactive oxygen species (ROS) and malondialdehyde (MDA), along with decreased expression of solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4). Conversely, HCAR1 overexpression or exposure to extracellular lactate inhibited ferroptosis and activated antioxidant defenses. Mechanistically, lactate activation of HCAR1 increases ATP levels, which in turn inactivates AMP-activated protein kinase (AMPK). It also upregulates stearoyl-CoA desaturase 1 (SCD1) through the sterol regulatory element binding protein 1 (SREBP1) signaling pathway. Blocking HCAR1 reversed these effects and restored ferroptosis sensitivity. Conclusion: HCAR1 mediates lactate-driven ferroptosis resistance in GC through the AMPK-SCD1 signaling pathway. Targeting the HCAR1-lactate axis may offer a promising strategy for overcoming metabolic adaptation and improving GC treatment outcomes.

26 February 2025 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
XCXun Cheng
Xun Cheng
HGHao Gu
Hao Gu
YCYulin Chong
Yulin Chong
FLFan Li
Fan Li
SBSonghua Bei
Songhua Bei
XZXiaohong Zhang
Xiaohong Zhang
Chronic atrophic gastritis (CAG) is a precancerous lesion characterised by gastric mucosal atrophy and inflammation. Identifying key molecular mechanisms and potential therapeutic targets is essential to improve patient outcomes. Key modules and differentially expressed genes (DEGs) were recognised in the GSE153224 dataset using weighted gene co‐expression network analysis (WGCNA) and examination of differential expression. IGFBP7 was identified as a hub gene by protein–protein interaction (PPI) network and expression validation. CAG patients’ blood parameters and gastric mucosal health status were evaluated before and after the treatment of vitamin C (VC). In addition, we investigated the effects of VC and N‐methyl‐N′‐nitro‐N‐nitrosoguanidine (MNNG) on GES‐1 cells, including cell viability, apoptosis and the expression of inflammatory and angiogenic markers. WGCNA identified that the blue module was significantly associated with CAG with a correlation coefficient 0.924. Among 93 overlapping genes, IGFBP7 was notably underexpressed and selected as a hub gene. ROC analysis confirmed the high diagnostic performance of IGFBP7. CAG patients treated with VC showed significant improvement in blood parameters and improved gastric mucosal health. In vitro, VC increased cell viability, reduced cytotoxicity and apoptosis and lowered COX‐2 and apoptosis‐related protein expression in MNNG‐treated GES‐1 cells. Knockdown of IGFBP7 further influenced these effects. MNNG upregulated HIF‐1α/VEGF signalling proteins, which VC attenuated. Combined VC and IGFBP7 knockdown showed potential protective effects. This study highlights the regulatory role of VC and IGFBP7 in CAG and demonstrates their potential as therapeutic targets for improving gastric mucosal health and mitigating inflammation.

25 February 2026 in International Immunopharmacology
Verified
Journal Article
Closed access
ZQZhe Qin
Zhe Qin
XZXiaohong Zhang
Xiaohong Zhang
XCXun Cheng
Xun Cheng